Viropharma, Inc. (NASDAQ: VPHM) reported Q3 EPS of ($0.07), $0.09 worse than the analyst estimate of $0.02. Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE